Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
4.135
+0.155 (3.89%)
At close: Nov 21, 2024, 4:00 PM
4.160
+0.025 (0.60%)
After-hours: Nov 21, 2024, 4:28 PM EST
Candel Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -52.2 | -37.94 | -18.79 | -36.12 | -17.68 | -8.24 |
| Depreciation & Amortization | 0.99 | 0.96 | 0.78 | 0.23 | 0.09 | 0.04 |
| Other Amortization | 0.3 | 0.32 | 0.29 | - | - | - |
| Loss (Gain) From Sale of Assets | 0 | 0.08 | - | - | - | - |
| Asset Writedown & Restructuring Costs | 0.23 | 0.39 | - | 0.55 | - | 1.26 |
| Stock-Based Compensation | 5.01 | 3.09 | 2.31 | 2.96 | 2.11 | 0.4 |
| Other Operating Activities | 15.83 | -0.62 | -16.07 | 11.03 | 4.64 | 0.84 |
| Change in Accounts Payable | 0.04 | 0.05 | -1.21 | 0.67 | 0.29 | 0.01 |
| Change in Unearned Revenue | -0.16 | -0.19 | 0.07 | -0.13 | -0.13 | -0.13 |
| Change in Other Net Operating Assets | 1.31 | -0.38 | 1.22 | -1.42 | 1.61 | 0.63 |
| Operating Cash Flow | -28.63 | -34.24 | -31.42 | -22.22 | -9.07 | -5.18 |
| Capital Expenditures | -0.06 | -0.46 | -1.3 | -1.84 | -1.48 | -0.16 |
| Sale of Property, Plant & Equipment | 0.02 | 0.18 | - | - | - | - |
| Cash Acquisitions | - | - | - | - | - | -0.85 |
| Investment in Securities | - | - | - | - | 39.93 | -34.74 |
| Investing Cash Flow | -0.04 | -0.28 | -1.3 | -1.84 | 38.46 | -35.74 |
| Short-Term Debt Issued | - | - | - | - | 0.46 | - |
| Long-Term Debt Issued | - | - | 19.91 | - | - | - |
| Total Debt Issued | - | - | 19.91 | - | 0.46 | - |
| Short-Term Debt Repaid | - | - | - | - | - | -0.52 |
| Total Debt Repaid | -6.67 | - | - | - | - | -0.52 |
| Net Debt Issued (Repaid) | -6.67 | - | 19.91 | - | 0.46 | -0.52 |
| Issuance of Common Stock | 9.03 | - | 0.06 | 71.8 | 0.03 | 0 |
| Repurchase of Common Stock | -0.12 | -0.12 | - | - | - | - |
| Financing Cash Flow | 2.25 | -0.12 | 19.97 | 71.8 | 0.49 | 21.98 |
| Net Cash Flow | -26.43 | -34.65 | -12.74 | 47.75 | 29.87 | -18.94 |
| Free Cash Flow | -28.69 | -34.7 | -32.72 | -24.05 | -10.55 | -5.34 |
| Free Cash Flow Margin | - | - | -26172.80% | -19242.40% | -8437.60% | -4268.80% |
| Free Cash Flow Per Share | -0.96 | -1.20 | -1.14 | -1.27 | -0.91 | -0.46 |
| Cash Interest Paid | 2.02 | 2.15 | 1.15 | - | - | - |
| Cash Income Tax Paid | - | - | 0.18 | 0.03 | 0.09 | 0.06 |
| Levered Free Cash Flow | -15.73 | -21.57 | -20.48 | -15.85 | -5.01 | - |
| Unlevered Free Cash Flow | -14.55 | -20.27 | -19.71 | -15.82 | -5.01 | - |
| Change in Net Working Capital | -1.73 | -0.13 | -0.21 | 1.1 | -2.9 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.